1. Fabbri LM, Celli BR, Agustí A, et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence. Lancet Respir Med. 2023;11(11):1020-1034. https://doi.org/10.1016/S2213-2600(23)00261-8
2. Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary. Eur Resp J. 2023;61(4). https://doi.org/10.1183/13993003.00239-2023
3. Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(9):e56-e69. https://doi.org/10.1164/rccm.202003-0625ST
4. Dixon J, Mendenhall E. Syndemic thinking to address multimorbidity and its structural determinants. Nat Rev Dis Primers. 2023 4;9(1):23. https://doi.org/10.1038/s41572-023-00437-2
5. Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995:80-94. https://doi.org/10.2307/2626958
6. Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941-950. https://doi.org/10.1016/S0140-6736(17)30003-X
7. Mendenhall E, Kohrt BA, Logie CH, Tsai AC. Syndemics and clinical science. Nat Med. 2022;28(7):1359-1362. https://doi.org/10.1038/s41591-022-01888-y
8. Tsai AC, Mendenhall E, Trostle JA, Kawachi I. Co-occurring epidemics, syndemics, and population health. Lancet. 2017;389(10072):978-982. https://doi.org/10.1016/S0140-6736(17)30403-8
9. Divo M, Celli BR. Multimorbidity in patients with chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):405-419. https://doi.org/10.1016/j.ccm.2020.06.002
10. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245-1257. https://doi.org/10.1183/09031936.00133805
11. Sin DD, Wu L, Man SFP. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127(6):1952-1959. https://doi.org/10.1378/chest.127.6.1952
12. Rabe KF, Hurst JR, Suissa S. Cardiovascular disease and COPD: dangerous liaisons? Eur Respir Rev. 2018;27(149). https://doi.org/10.1183/16000617.0057-2018
13. Sin DD, Man JP, Man SFP. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114(1):10-14. https://doi.org/10.1016/S0002-9343(02)01297-4
14. Vikjord SAA, Brumpton BM, Mai X-M, Bhatta L, Vanfleteren L, Langhammer A. The association of bone mineral density with mortality in a COPD cohort. The HUNT Study, Norway. COPD. 2019;16(5-6):321-329. https://doi.org/10.1080/15412555.2019.1685482
15. Looker AC. Relationship between femur neck bone mineral density and prevalent chronic obstructive pulmonary disease (COPD) or COPD mortality in older non-Hispanic white adults from NHANES III. Osteoporos Int. 2014;25(3):1043-1052. https://doi.org/10.1007/s00198-013-2601-5
16. Agustí A, Melén E, DeMeo DL, Breyer-Kohansal R, Faner R. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med. 2022;10(5):512-524. https://doi.org/10.1016/S2213-2600(21)00555-5
17. Bush A. Impact of early life exposures on respiratory disease. Paediatr Respir Rev. 2021;40:24-32. https://doi.org/10.1016/j.prrv.2021.05.006
18. Burke H, Wilkinson TMA. Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care. Eur Respir Rev. 2021;30(160). https://doi.org/10.1183/16000617.0041-2021
19. Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol. 2001;30(4):668-677. https://doi.org/10.1093/ije/30.4.668
20. Anda RF, Brown DW, Dube SR, Bremner JD, Felitti VJ, Giles WH. Adverse childhood experiences and chronic obstructive pulmonary disease in adults. Am J Prev Med. 2008;34(5):396-403. https://doi.org/10.1016/j.amepre.2008.02.002
21. Singh GK, Lin C-CC. Area Deprivation and inequalities in health and health care outcomes. Ann Intern Med. 2019;171(2):131-132. https://doi.org/10.7326/M19-1510
22. Massey DS, Denton NA. American Apartheid: Segregation and the Making of the Underclass. Harvard University Press; 1993.
23. Galiatsatos P, Kineza C, Hwang S, et al. Neighborhood characteristics and health outcomes: evaluating the association between socioeconomic status, tobacco store density and health outcomes in Baltimore City. Tob Control. 2018;27(e1):e19-e24. https://doi.org/10.1136/tobaccocontrol-2017-053945
24. Steptoe A, Feldman PJ. Neighborhood problems as sources of chronic stress: development of a measure of neighborhood problems, and associations with socioeconomic status and health. Ann Behav Med. 2001;23(3):177-185. https://doi.org/10.1207/S15324796ABM2303_5
25. Liu J, Clark LP, Bechle MJ, et al. Disparities in air pollution exposure in the United States by race/ethnicity and income, 1990-2010. Environ Health Perspect. 2021;129(12):127005. https://doi.org/10.1289/EHP8584
26. Pleasants RA, Riley IL, Mannino DM. Defining and targeting health disparities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2475-2496. https://doi.org/10.2147/COPD.S79077
27. Galiatsatos P, Woo H, Paulin LM, et al. The association between neighborhood socioeconomic disadvantage and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:981-993. https://doi.org/10.2147/COPD.S238933
28. Hayes S, Duan KI, Wai TH, et al. Association between neighborhood socioeconomic disadvantage and chronic obstructive pulmonary disease prevalence among U.S. Veterans. Ann Am Thorac Soc. 2024; 21(4): 669-672. https://doi.org/10.1513/AnnalsATS.202308-668RL
29. Ejike CO, Woo H, Galiatsatos P, et al. Contribution of individual and neighborhood factors to racial disparities in respiratory outcomes. Am J Respir Crit Care Med. 2021;203(8):987-997. https://doi.org/10.1164/rccm.202002-0253OC
30. Lin C-H, Cheng S-L, Chen C-Z, Chen C-H, Lin S-H, Wang H-C. Current progress of COPD early detection: key points and novel strategies. Int J Chron Obstruct Pulmon Dis. 2023;18:1511-1524. https://doi.org/10.2147/COPD.S413969
31. Diab N, Gershon AS, Sin DD, et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130-1139. https://doi.org/10.1164/rccm.201804-0621CI
32. Keller TL, Wright J, Donovan LM, et al. Association of patient and primary care provider factors with outpatient COPD care quality. Chronic Obstr Pulm Dis. 2022;9(1):55-67. https://doi.org/10.15326/jcopdf.2021.0232
33. Keller T, Spece LJ, Donovan LM. Association of guideline-recommended COPD inhaler regimens with mortality, respiratory exacerbations, and quality of life: a secondary analysis of the Long-Term Oxygen Treatment Trial. Chest. 2020;158(2):529-538. https://doi.org/10.1016/j.chest.2020.02.073
34. Mendenhall E, Kohrt BA, Norris SA, Ndetei D, Prabhakaran D. Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations. Lancet. 2017;389(10072):951-963. https://doi.org/10.1016/S0140-6736(17)30402-6
35. Kerr M, Tarabichi Y, Evans A, et al. Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program. Lancet Reg Health Am. 2023;24:100546. https://doi.org/10.1016/j.lana.2023.100546
36. Tribble SJ. Many COPD patients struggle to pay for each breath. National Public Radio website. Published June 2017. Accessed September 2024 https://www.npr.org/sections/health-shots/2017/06/02/529759280/many-copd-patients-struggle-to-pay-for-each-breath
37. Bloom CI, Douglas I, Olney J, D'Ancona G, Smeeth L, Quint JK. Cost saving of switching to equivalent inhalers and its effect on health outcomes. Thorax. 2019;74(11):1078-1086. https://doi.org/10.1136/thoraxjnl-2018-212957
38. Agarwal SD, Metzler E, Chernew M, et al. Reduced cost sharing and medication management services for COPD: a randomized clinical trial. JAMA Intern Med. 2024;e243499. https://doi.org/10.1001/jamainternmed.2024.3499
39. Illinois House passes bill making prescription inhalers more affordable [news release]. Springfield, IL; American Lung Association; May 22, 2024. Accessed September 2024. https://www.lung.org/media/press-releases/illinois-house-passes-inhaler-bill-law
40. Ruzieh M, Baugh AD, Al Jebbawi L, et al. Beta-blocker use in patients with chronic obstructive pulmonary disease: a systematic review: a systematic review of betaB in COPD. Trends Cardiovasc Med. 2023;33(1):53-61. https://doi.org/10.1016/j.tcm.2021.11.004
41. Lichtman SM, Harvey RD, Damiette Smit M-A, et al. Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group. J Clin Oncol. 2017;35(33):3753-3759. https://doi.org/10.1200/JCO.2017.74.4102
42. Bibbins-Domingo K, Helman A, eds. Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. National Academies Press; 2022. Accessed September 2024. https://nap.nationalacademies.org/catalog/26479/improving-representation-in-clinical-trials-and-research-building-research-equity
43. Putcha N, Han MK, Martinez CH, et al; the COPDGene® Investigators. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis. 2014;1(1):105-114. https://doi.org/10.15326/jcopdf.1.1.2014.0112
44. Au DH, Collins MP, Berger DB, et al. Health system approach to improve chronic obstructive pulmonary disease care after hospital discharge: stepped-wedge clinical trial. Am J Respir Crit Care Med. 2022;205(11):1281-1289. https://doi.org/10.1164/rccm.202107-1707OC
45. Portillo E, Lehmann M, Hagen T, et al. Evaluation of an implementation package to deliver the COPD CARE service. BMJ Open Qual. 2023;12(1):e002074. https://doi.org/10.1136/bmjoq-2022-002074
46. Centers for Medicare and Medicaid Services (CMS). Value-based care. CMS website. Accessed September 2024. https://www.cms.gov/priorities/innovation/key-concepts/value-based-care .
47. Liao JM, Lavizzo-Mourey RJ, Navathe AS. A national goal to advance health equity through value-based payment. JAMA. 2021;325(24):2439-2440. https://doi.org/10.1001/jama.2021.8562
48. U.S. Veterans Affairs (VA). Whole health-whole health basics. VA website. Updated January 16, 2024. Accessed September 2024. https://www.va.gov/WHOLEHEALTH/veteran-resources/whole-health-basics.asp
49. Mendenhall E, Newfield T, Tsai AC. Syndemic theory, methods, and data. Soc Sci Med. 2022;295:114656. https://doi.org/10.1016/j.socscimed.2021.114656
50. Mendenhall E. Syndemic Suffering: Social Distress, Depression, and Diabetes among Mexican Immigrant Women. Routledge, Taylor & Francis Group;2012.
51. Tsai AC. Syndemics: a theory in search of data or data in search of a theory? Soc Sci Med. 2018;206:117-122. https://doi.org/10.1016/j.socscimed.2018.03.040
52. Brewis A, Wutich A, Galvin M, Lachaud J. Localizing syndemics: A comparative study of hunger, stigma, suffering, and crime exposure in three Haitian communities. Soc Sci Med. 2022;295:113031. https://doi.org/10.1016/j.socscimed.2020.113031
53. Centers for Disease Control and Prevention (CDC). PLACES: local data for better health CDC website. Updated August 2024. Accessed September 2024. https://www.cdc.gov/places/index.html
54. The Public Health Alliance of Southern California. California Healthy Places Index. California Health Places website. Published 2022. Accessed September 2024. https://www.healthyplacesindex.org/ .
55. Yerramilli P, May FP, Kerry VB. Reducing health disparities requires financing people-centered primary care. JAMA Health Forum. 2021;2(2):e201573. https://doi.org/10.1001/jamahealthforum.2020.1573